Diagnostic performance of 18F-FDG PET-CT and SPECT for bone metastases from colorectal cancer: a retrospective study - Scorecard - MDSpire

Diagnostic performance of 18F-FDG PET-CT and SPECT for bone metastases from colorectal cancer: a retrospective study

  • By

  • Fangyi Gong

  • Yu Fang

  • Ting Ge

  • Yuanjin Gong

  • Bo Zhang

  • Baiwen Hu

  • June 12, 2026

  • 0 min

Share

Clinical Scorecard: Evaluating the Diagnostic Efficacy of 18F-FDG PET-CT Versus SPECT for Identifying Bone Metastases in Colorectal Cancer: A Retrospective Analysis

At a Glance

CategoryDetail
Condition
Key Mechanisms
Target PopulationPatients with pathologically confirmed colorectal cancer, aged 48 to 75, including 62 males and 56 females.
Care Setting

Key Highlights

  • additional_context

Guideline-Based Recommendations

Diagnosis

    Management

    • Consider specific treatment protocols based on imaging results.

    Monitoring & Follow-up

    • Regular follow-up imaging to assess treatment response.

    Risks

      Patient & Prescribing Data

      Clinical Best Practices

      • rationale

      Related Resources & Content

      Original Source(s)

      Diagnostic performance of 18F-FDG PET-CT and SPECT for bone metastases from colorectal cancer: a retrospective study

      • by Fangyi Gong, Yu Fang, Ting Ge, Yuanjin Gong, Bo Zhang, Baiwen Hu

      • June 12, 2026

      Related Content

      Editorial: Innovative organoid co-culture systems for enhanced precision medicine in cancer and beyond

      Beyond prediction: AI as a mechanistic microscope and digital twin for colorectal cancer immunotherapy

      Intra-procedural CT control versus ultrasound only in ultrasound-guided thermal ablation of colorectal liver metastases: a single-centre cohort study